Asitri Dashboard
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 448
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT03568526 | Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer | ||
NCT05845476 | Sexual Orientation and Gender Identity (SOGI) Data Collection Program Implementation and Evaluation | ||
NCT06026657 | Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer | ||
NCT05012176 | An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors | ||
NCT00276120 | Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer | ||
NCT00417976 | Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer | ||
NCT04427566 | Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise | ||
NCT02107755 | Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma | ||
NCT00486525 | Hatha Yoga in Improving Physical Activity, Inflammation, Fatigue, and Distress in Breast Cancer Survivors | ||
NCT02150525 | Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors | ||
NCT00143065 | Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ||
NCT02944565 | Daratumumab in Treating Patients With Multiple Myeloma | ||
NCT03372720 | Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors | ||
NCT03578627 | Stress and Immunity Breast Cancer Project | ||
NCT02831582 | Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer | ||
NCT01929720 | Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors | ||
NCT03364582 | Dietary Patterns, Metabolomics and Colorectal Cancer Risk | ||
NCT02950220 | Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma | ||
NCT04267874 | Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study | ||
NCT00852774 | Steep Trendelenburg Positioning on Intra-Ocular Pressure During Surgery for Endometrial Robotics Versus Laparotomy | ||
NCT05106374 | Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer | ||
NCT03824327 | Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases | ||
NCT00201773 | Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer | ||
NCT05641831 | Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study | ||
NCT00293527 | Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma | ||
NCT04340531 | Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities | ||
NCT02569320 | HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma | ||
NCT06500065 | 68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas | ||
NCT05417165 | Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia | ||
NCT04906382 | Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer | ||
NCT00201682 | Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma | ||
NCT00004173 | Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer | ||
NCT05453773 | Hookah Additive Research to Inform Product Standards | ||
NCT01462773 | Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma | ||
NCT00201760 | Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer | ||
NCT06016725 | Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial | ||
NCT00863122 | Concentration and Activity of Lapatinib in Vestibular Schwannomas | ||
NCT02120222 | Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery | ||
NCT06582030 | Stop Addiction Stigma | ||
NCT00201825 | A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients | ||
NCT01740648 | Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer | ||
NCT02760030 | Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery | ||
NCT05665725 | Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma | ||
NCT02017925 | Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation | ||
NCT02090530 | Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing | ||
NCT06424522 | A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients | ||
NCT02262325 | Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery | ||
NCT00428922 | Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients | ||
NCT02992522 | Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma | ||
NCT04049539 | Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction |